The present disclosure relates generally to packaging for a plurality of medical containers and, more specifically, to packaging for the plurality of medical containers that limits separation of the containers at least prior to use.
Some drugs are intended for concurrent use. For example, a first drug may be administered initially to improve the conditions under which a second drug is delivered to or processed by a patient. Conventionally, this requires the healthcare professional administering the drugs to collect the drugs from storage, to verify the identity of the drugs, to verify the concentration of the drugs, and then to perform the administration of the drugs.
As a consequence, there are a number of issues that may arise. The professional may obtain the incorrect drugs, or may misidentify the drugs. He or she may also fail to misidentify the concentration of the drugs. Having collected the drugs and identified them correctly, he or she may also fail to transport them to the patient. The bottles, vials or other containers may be mishandled, and could even end up damaged or broken. Any of these issues may have a negative effect on the administration of the drugs to the patient, and on the health of the patient.
As set forth in more detail below, the present disclosure sets forth an improved packaging device embodying advantageous alternatives to the conventional packaging assemblies discussed above.
According to an aspect of the present disclosure, a system includes a first container having a wall defining a receptacle, a neck defining an opening, and a flip cap disposed over the opening, and a second container having a wall defining a receptacle, a neck defining an opening, and a flip cap disposed over the opening. The system also includes a carrier having first and second carrier pieces disposed about the first and second containers and attached together with the first and second containers secured therebetween. The system further includes a top cap attached to the flip caps to secure the first and second containers together and to simultaneously remove the flip caps from the containers.
Additional aspects of the disclosure are defined by the claims of this patent.
It is believed that the disclosure will be more fully understood from the following description taken in conjunction with the accompanying drawings. Some of the figures may have been simplified by the omission of selected elements for the purpose of more clearly showing other elements. Such omissions of elements in some figures are not necessarily indicative of the presence or absence of particular elements in any of the exemplary embodiments, except as may be explicitly delineated in the corresponding written description. None of the drawings is necessarily to scale.
Referring first to
As to the details of the system 100, it will be recognized that the first container 102 has front portion 110, a back portion 112, a top 114, and a bottom 116. The back (or second) portion 112 is disposed opposite the front (or first) portion 110, while the bottom 116 is disposed opposite the top 114. Moreover, the container 102 includes a wall 118 that defines a receptacle 120, a shoulder 122, and a neck 124 (see also
In a similar fashion, the second container 104 has a front portion 140, a back portion 142, a top 144, and a bottom 146. Moreover, the container 104 includes a wall 148 defining a receptacle 150, a shoulder 152, and a neck 154 (see also
While the first and second containers 102, 104 are generally cylindrical in shape, they may take the form of various other shapes and still be included within the scope of the disclosure. The containers, which may also be referred to as vials or bottles, may be made of glass or plastic, for example. Further, typically, the first container 102 may be a large container having a large volume of medication, and the second container 104 may be a small container having a small volume of medication. In other words, the volume of medication in the first container 102 is greater that the volume of medication in the second container 104. However, both volumes of medication may represent (and according to certain embodiments, are) a single dose.
In one example, the first container 102 may be a glass vial adapted to hold 100 mL of a Gammaguard liquid, and the second container 104 may be a glass vial adapted to hold 5 mL of a Hylenex liquid. These medications, however, are one example only. One of skill in the art will appreciate that the medications in the first and second containers 102, 104 may include various other medications and may be administered together in a single dose or multiple doses.
As mentioned above, the system 100 also includes a carrier 106 that is disposed about the first and second containers 102, 104 to secure the same together at least until use. As illustrated in
According to the present disclosure and as best seen in
The latches 174, 176, 178, 180, 182 and recesses 184, 186, 188, 190, 192 may be disposed about the first and second carrier pieces 170, 172 in the following fashion.
The first carrier piece 170 has a top portion 200, a central portion 202, and a base portion 204, and the second carrier piece 172 likewise has a top portion 210, a central portion 212, and a base portion 214. The latch 174 of the first carrier piece 170 is disposed on a central area of the top portion 200, and the associated recess 184 of the second carrier piece 172 is disposed on a central area of the top portion 210. In addition, the top portion 200 of the first carrier piece 170 may include two additional latches 176, 178, one of which may be disposed on a first side of the top portion 200 and the other of which may be disposed on a second side of the top portion 200 opposite the first side (i.e., on opposite sides of the top portion 200 relative to the central area where the latch 174 is disposed). The recesses 186, 188 associated with these latches 176, 178 are disposed on opposite sides of the top portion 210 of the second carrier piece 172. Phrased slightly differently, the first latch/recess pair 174, 184 is disposed between the first and second containers 102, 104, with the first container 102 disposed between the latch/recess pairs 174, 184 and 176, 186 and the second container 104 is disposed between the latch/recess pairs 174, 184 and 178, 188.
As also seen in
In regard to the latch/ recess pairs 174, 184 and 180, 190, it will be noted that the recesses 184, 190 are U-shaped, which shape may assist in guiding the latches 174, 180 into the same and also may assist in smooth engagement of the latches 174, 180 and the associated recesses 184, 190. While the recesses 184, 190 are U-shaped as illustrated, one of skill in the art will appreciate that the recesses 184, 190 be formed using other shapes and still fall within the scope of the disclosure. Such shapes may include an inverted U-shape, a semicircle, and an inverted semi-circle, for example. As illustrated, the latches 174, 180 are loop latches, which deflect during assembly, thus keeping assembly forces low, but resisting release in tension and shear, for example. The connection between the latch/ recess pairs 174, 184 and 180, 190 may provide the majority of resistance to separation of the first and second carrier pieces 170, 172.
In regard to the latch/recess pairs 176, 186 and 178, 188, these latch/recess pairs assist in securing the carrier 106 to and about the first and second containers 102, 104. According to the illustrated embodiment and as best seen in
The carrier 106, and in particular the carrier pieces 170, 172, may include other features as well.
For example, as illustrated, the top portions 200, 210 of the first and second carrier pieces 170, 172 may each include a section 220, 222, 224, 226 (see
As will also be recognized from
Also according to the present disclosure, each of the first and second carrier pieces 170, 172 may include a stabilizer 240, 242 (see
Referring now specifically as to
Returning to
It will also be recognized that because the carrier 106, and in particular the collars 228, 230, holds the containers 102, 104 so that the tops 114, 144 of each are at a common level and because the containers 102, 104 are not of an equal size, there is a space 260 located opposite the container 102 beneath the container 104. A grip 262 is disposed in the space 260 (see
As best illustrated in
Finally, with reference to
The first and second carrier pieces 170, 172 may each be made, in whole or in part, of a clear material that allows a user to view the first and second containers 102, 104 through the first and second carrier pieces 170, 172. Clear may be defined as transparent, translucent, or opaque, for example. In one example, the first and second carrier pieces 170, 172 may each be made of a plastic resin, such as copolyester, which combines high clarity with acceptable mechanical properties. One of the skill in the art will appreciate that various other materials may also be used that allow the first and second containers 102, 104 to be viewed through the first and second carrier pieces 170, 172.
Referring back to
As illustrated in
According to the embodiment illustrated in
For example, with reference to
In particular, the lever 302 depends from the top cap 300 along the side of the carrier 106 in a first, storage or pre-operative state. The lever 302 includes a main section 304 and a connecting section 306, which sections 304, 306 are joined to each other and to the top cap 300 through hinges 308, 310. The hinges 308, 310 may be living hinges, as illustrated, and may be defined by sections of reduced thickness along the length of the lever 302. The lever 302 may be folded at the hinges 308, 310 so that the lever lies across the top cap 300, as illustrated in
To move the lever from the storage state to the operative state, the user first grips the main section 304, and applies an upwardly and outwardly directed force. This may cause the lever 302 to bend about one or both of the hinges 308, 310. As illustrated in
To assemble the system 100, the containers 102, 104 may be disposed such that the necks 124, 154 are received within the sections 220, 222 of the first carrier piece 170 or the sections 224, 226 of the second carrier piece 172. The carrier pieces 170, 172 may then be brought together such that the latches 174, 176, 178, 180, 182 are received in the recesses 184, 186, 188, 190, 192. With the latches 174, 176, 178, 180, 182 fully received within the recesses 184, 186, 188, 190, 192, the carrier pieces 170, 172 are connected to each other such that at least a portion (i.e., the necks 124, 154) of the containers 102, 104 is disposed therebetween such that the carrier 106 resists the separation of the containers 102, 104 from the carrier 106, and thus resists separation of the containers 102, 104 from each other. It may also be said that the carrier 106 is secured to the containers 102, 104. At this point, the top cap 108 may be disposed on the tops 114, 144 of the containers 102, 104, such that the fasteners 280 of the top cap 108 engage the flip caps 128, 158 of the containers 102, 104, at least at an edge 288, 290 of the containers 102, 104. At this point, it may also be said that the top cap 108 is secured to the flip caps 128, 158.
At the time of use, the containers 102, 104 will be associated with each other as a consequence of the carrier 106. To provide access to the contents of the containers 102, 104, an upwardly directed force may be applied to the tab 294 of the top cap 108 of the embodiment of
It is believed that the container system according to the present disclosure may provide one or more advantages, one or more of which may be provided in a particular embodiment of the present disclosure. The system 100 assists in maintaining the association of the first container 102 and the second container 104 at least until use, and in ensuring that both flip caps 128, 158 of the first and second containers 102, 104 are opened together. As a result, the system 100 may also assist in decreasing the risk that the medication in both containers is inappropriately or incorrectly administered to a patient. Additional features may provide additional advantages. For example, the carrier 106, and in particular the grip 262, allows for easier handling of the containers 102, 104 during administration of the medication, for example. In addition, the skid pad 270 of the system 100 help stabilize the containers 102, 104 when they are placed on a surface, for example, making administration of the medication more efficient.
Although the foregoing text sets forth a detailed description of different embodiments of the invention, it should be understood that the legal scope of the invention is defined by the words of the claims set forth at the end of this patent. The detailed description is to be construed as exemplary only and does not describe every possible embodiment of the invention since describing every possible embodiment would be impractical, if not impossible. Numerous alternative embodiments could be implemented, using either current technology or technology developed after the filing date of this patent, which would still fall within the scope of the claims defining the invention.
It should also be understood that, unless a term is expressly defined in this patent using the sentence “As used herein, the term ‘——————’ is hereby defined to mean . . . ” or a similar sentence, there is no intent to limit the meaning of that term, either expressly or by implication, beyond its plain or ordinary meaning, and such term should not be interpreted to be limited in scope based on any statement made in any section of this patent (other than the language of the claims). To the extent that any term recited in the claims at the end of this patent is referred to in this patent in a manner consistent with a single meaning, that is done for the sake of clarity only so as to not confuse the reader, and it is not intended that such claim term be limited, by implication or otherwise, to that single meaning. Finally, unless a claim element is defined by reciting the word “means” and a function without the recital of any structure, it is not intended that the scope of any claim element be interpreted based on the application of 35 U.S.C. §110, sixth paragraph.
It should be understood other changes and modifications to the presently preferred embodiments described herein would also be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
363690 | Sleeper | May 1887 | A |
2080947 | Ligeour | May 1937 | A |
2399893 | Scholz | May 1946 | A |
2754962 | Scrymgeour | Jul 1956 | A |
2865669 | Linthicum | Dec 1958 | A |
2949204 | Edwards | Aug 1960 | A |
3278007 | Weber | Oct 1966 | A |
3589509 | Mascia et al. | Jun 1971 | A |
3593873 | Vonk | Jul 1971 | A |
3601253 | Poupitch | Aug 1971 | A |
3727749 | Martin | Apr 1973 | A |
3744661 | Fischer, Jr. | Jul 1973 | A |
3893280 | King | Jul 1975 | A |
4143764 | Moss, III | Mar 1979 | A |
4262814 | Roccaforte | Apr 1981 | A |
4856647 | Dahne | Aug 1989 | A |
5005721 | Jordan | Apr 1991 | A |
5009309 | Hansen | Apr 1991 | A |
5040678 | Lenmark, Sr. et al. | Aug 1991 | A |
5148919 | Rubin | Sep 1992 | A |
5609248 | Rohrbough et al. | Mar 1997 | A |
5725499 | Silverstein et al. | Mar 1998 | A |
5954213 | Gerhart et al. | Sep 1999 | A |
6000548 | Tsals | Dec 1999 | A |
6102233 | Waugh | Aug 2000 | A |
6164450 | Benedetti | Dec 2000 | A |
6213529 | Kurcz et al. | Apr 2001 | B1 |
6305541 | Tanner et al. | Oct 2001 | B1 |
6558628 | Reo | May 2003 | B1 |
6613283 | Reo | Sep 2003 | B2 |
6789828 | Borg | Sep 2004 | B1 |
6929474 | Schenck et al. | Aug 2005 | B2 |
7468049 | Laveault | Dec 2008 | B2 |
20050045495 | Dalsing et al. | Mar 2005 | A1 |
20070278245 | Brooks et al. | Dec 2007 | A1 |
Number | Date | Country |
---|---|---|
0495808 | Jul 1992 | EP |
0631816 | Jan 1995 | EP |
0734963 | Oct 1996 | EP |
2085307 | Dec 1971 | FR |
2715131 | Jul 1995 | FR |
08-324571 | Dec 1996 | JP |
WO 9301739 | Feb 1993 | WO |
WO9632917 | Oct 1996 | WO |
WO 2009083347 | Jul 2009 | WO |
Entry |
---|
International Search Report and Written Opinion from corresponding International Application No. PCT/US2013/036879, mail date Jul. 26, 2013. |
Number | Date | Country | |
---|---|---|---|
20130284735 A1 | Oct 2013 | US |